No Data
No Data
Sinolink: The results of the negotiations on drug prices in the United States have been announced, and the continuous procurement of medical devices domestically is ongoing.
Bullish on the development of the domestic medical devices industry in the second half of the year, with the industry's purchasing demand expected to accelerate recovery. At the same time, domestic leading companies in sub-sectors such as ultrasound and endoscopy, due to their strong competitiveness, are expected to further increase market share, with sales growth and profitability expected to return to an upward trend.
United Lab rose more than 9% after a profitable earnings report and is expected to see a nearly 13% year-on-year increase in net profit to 1.45 billion yuan in the first half of the year.
Shares of United Lab (03933) rose more than 9%. At the time of publication, it was up 9.57% to HKD 9.39 with a turnover of HKD 44.1404 million and a total market capitalization of HKD 17.062 billion.
United Laboratories International Sees 1H Net CNY1.45B Vs. CNY1.28B Year Earlier >3933.HK
United Laboratories International: Results Supported Mainly Due to Cost Reduction >3933.HK
United Lab (03933.HK) Profit Express: Expected half year net profit of approximately 1.45 billion yuan.
On August 15th, Glonhui reported that the expected net profit for the group for the six months ending June 30, 2024, is about RMB 1.45 billion, while the net profit for the six months ending June 30, 2023, was about RMB 1.284 billion. The increase in net profit is mainly due to: (1) the increase in intermediate product revenue and continuous reduction in production costs, driving a gross profit increase of about RMB 0.13 billion; and (2) the reduction of sales and distribution expenses by about RMB 0.26 billion, offsetting the increase in research and development costs of about RMB 0.1 billion.
Express News | United Laboratories International Sees Increase in Hy Gross Profit of RMB130 Mln
No Data